MOSCOW (MRC) -- INOVYN announces the completion of its new large scale potassium hydroxide (KOH) production facility at its Antwerp/Lillo Site (Belgium), as per the company's press release.
The first production run of membrane quality KOH for supply to customers took place during the first week of October, following successful start-up of the facility.
Comments Filipe Constant, Business Director for INOVYN: ЭWe are delighted to have achieved this significant milestone in the ongoing evolution of INOVYN, which is the culmination of a two year Project. The Project has been delivered fully to plan and with an excellent safety, health and environmental performance record.
"This major investment not only underpins INOVYN’s leading position in KOH, but will deliver our commitment to long-term continuity of supply to our customers."
INOVYN’s new KOH plant (155kT of KOH with 100kT of chlorine) uses the latest membrane technology and forms a key part of INOVYN’s Chlorine Strategy.
Antwerp/Lillo Site was selected for the investment as it is well situated to serve customers both in Europe and beyond, with the nearby Port of Antwerp facilitating KOH movements by ship. The Site is a highly competitive location given it has major customers for the co-produced chlorine, which are linked directly to the Site by pipeline. It is also strategically positioned for imports of potassium chloride, a key raw material in KOH production.
As MRC informed before, Inovyn was formed on 1 July 2015 as a jv between Ineos and SolVin, a subsidiary of Solvay. Solvay and Ineos signaled their decision to end their chlorvinyls jv in March this year. And in July 2016, Solvay completed the divestment of its shareholding in Inovyn (London), bringing to an end Solvay's chlorvinyls joint venture with Ineos.
Headquartered in London, INOVYN has pro-forma sales of more than EUR3 billion, with 4,300 employees and assets across 14 sites in Belgium, France, Germany, Italy, Norway, Spain, Sweden and the UK. Governance of the Joint Venture is equally split between the partners.
MRC